X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21) 21
index medicus (18) 18
male (18) 18
female (16) 16
aged (15) 15
middle aged (14) 14
oncology (14) 14
chemotherapy (11) 11
cancer (10) 10
adult (9) 9
clinical trials (8) 8
metastasis (8) 8
patients (8) 8
treatment outcome (8) 8
aged, 80 and over (7) 7
metastases (7) 7
survival (7) 7
analysis (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
docetaxel (5) 5
italy (5) 5
lung cancer (5) 5
quality of life (5) 5
retrospective studies (5) 5
safety (5) 5
breast cancer (4) 4
cancer therapies (4) 4
carcinoma, non-small-cell lung - drug therapy (4) 4
care and treatment (4) 4
castration-resistant prostate cancer (4) 4
cisplatin - administration & dosage (4) 4
deoxycytidine - analogs & derivatives (4) 4
disease-free survival (4) 4
gemcitabine (4) 4
lung cancer, non-small cell (4) 4
lung neoplasms - drug therapy (4) 4
neoplasm metastasis (4) 4
neoplasm staging (4) 4
outcomes (4) 4
prostate cancer (4) 4
prostatic neoplasms, castration-resistant - drug therapy (4) 4
urology & nephrology (4) 4
vinblastine - administration & dosage (4) 4
vinblastine - analogs & derivatives (4) 4
abiraterone acetate (3) 3
adenocarcinoma - drug therapy (3) 3
androgens (3) 3
animals (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
carboplatin (3) 3
carcinoma, non-small-cell lung - pathology (3) 3
cisplatin (3) 3
deoxycytidine - administration & dosage (3) 3
drug therapy (3) 3
estrogen receptor alpha - metabolism (3) 3
hematology, oncology and palliative medicine (3) 3
immunohistochemistry (3) 3
inhibition (3) 3
liver (3) 3
lizards (3) 3
metaanalysis (3) 3
neutropenia (3) 3
physiological aspects (3) 3
prospective studies (3) 3
radiation therapy (3) 3
survival rate (3) 3
taxoids - administration & dosage (3) 3
trial (3) 3
tumors (3) 3
vascular endothelial growth factor (3) 3
vinorelbine (3) 3
adenocarcinoma - pathology (2) 2
alexithymia (2) 2
androstenes - therapeutic use (2) 2
anthracycline (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antineoplastic agents, immunological - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
aortic valve - surgery (2) 2
aortic valve stenosis - surgery (2) 2
biopsy (2) 2
blotting, western (2) 2
brain neoplasms - drug therapy (2) 2
brain neoplasms - secondary (2) 2
breast neoplasms - drug therapy (2) 2
breast neoplasms - pathology (2) 2
carboplatin - administration & dosage (2) 2
carcinoma (2) 2
case report (2) 2
chemotherapy, adjuvant - utilization (2) 2
clinical-trials (2) 2
cohort studies (2) 2
colorectal neoplasms - drug therapy (2) 2
colorectal neoplasms - pathology (2) 2
compassionate use trials (2) 2
diagnosis (2) 2
disease progression (2) 2
drug administration schedule (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2007, Nisaba / Dipartimento di scienze dell'antichit©¿ dell'Universit©¿ di Messina, ISBN 888268010X, Volume 17, 178
Book
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 5/2019, Volume 27, Issue 5, pp. 1801 - 1809
The aim of this randomized clinical trial was to examine the efficacy of Pennebaker’s expressive writing intervention (EWI) in improving the perceived quality... 
Pain Medicine | Nursing | Rehabilitation Medicine | Randomized clinical trial | Medicine & Public Health | Nursing Research | Expressive writing intervention | Alexithymia | Oncology | Psychopathology | Cancer | Quality of life
Journal Article
2006, Nisaba / Dipartimento di scienze dell'antichità dell'Università di Messina, ISBN 888268010X, Volume 13, 131
Book
BJU International, ISSN 1464-4096, 05/2015, Volume 115, Issue 5, pp. 764 - 771
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 68, Issue 1, pp. 147 - 153
Journal Article
by Vergote, Ignace and Scambia, Giovanni and O'Malley, David and O'Malley, David M and Van Calster, Ben and Park, Sang-Yoon and Park, Sang Yoon and del Campo, Josep M and Meier, Werner and Bamias, Aristotelis and Colombo, Nicoletta and Wenham, Robert M and Wenham, Robert and Covens, Allan and Covens, Al and Marth, Christian and Raza Mirza, Mansoor and Kroep, Judith and Kroep, Judith R and Ma, Haijun and Pickett, Cheryl A and Monk, Bradley J and Monk, Bradley and Song, Yong Sang and Makarova, Yulia and Trinidad, Joshua and Ngan, Hextan Yuen Sheung and Aravantinos, Gerasimos and Nam, Joo-Hyun and Gorbunova, Vera and Krikunova, Ludmila and Bae, Duk-Soo and Arija, Jose Angel Arranz and Mirza, Mansoor Raza and Zamagni, Claudio and Papandreou, Christos and Raspagliesi, Francesco and Lisyanskaya, Alla and Benzaquen, Ana Oaknin and Tognon, Germana and Ortega, Eugenia and Herraez, Antonio Casado and Buscema, Joseph and Green, Andrew and Burger, Robert and Sakaeva, Dina and Sanchez, Andres Redondo and Ghamande, Sharad and King, Laurel and Petru, Edgar and Peen, Ulla and Takeuchi, Satoshi and Ushijima, Kimio and Martin, Antonio Gonzalez and Kamelle, Scott and Carney, Michael and Forget, Frédéric and Bentley, James and Sehouli, Jalid and Zola, Paolo and Kato, Hidenori and Fadeeva, Natalya and Gotovkin, Evgeny and Vladimirov, Vladimir and Marin, Margarita Romeo and Alia, Eva Guerra and Shahin, Mark and Bhoola, Snehalkumar and Tewari, Krishnansu and Anderson, Daniel and Anderson, Jeanne and Honhon, Brigitte and Pelgrims, Joseph (Gino) and Oza, Amit and Jimenez, Jesus Garcia-Donas and Hansen, Vincent and Benjamin, Ivor and Renard, Vincent and Van den Bulck, Heidi and Haenle, Claudia and Koumakis, Georgios and Yokota, Harushige and Popov, Vadim and Bradley, William and Reid, Robert and Reid, Gary and McNamara, Donna and Friedman, Richard and Barlin, Joyce and Spirtos, Nicola and Chapman, Julia and Sevelda, Paul and Huizing, Manon and Lamot, Caroline and Goffin, Frédéric and Hondt, Lionel D and Spadafora, Silvana and Rautenberg, Beate and Reimer, Toralf and Möbus, Volker and ... and TRINOVA-3 ENGOT-ov2 GOG-3001 Inves and TRINOVA-3/ENGOT-ov2/GOG-3001 investigators
The Lancet Oncology, ISSN 1470-2045, 06/2019, Volume 20, Issue 6, pp. 862 - 876
Angiopoietin 1 and 2 regulate angiogenesis and vascular remodelling by interacting with the tyrosine kinase receptor Tie2, and inhibition of angiogenesis has... 
WOMEN | THERAPY | INHIBITION | ANGIOGENESIS | ONCOLOGY | FUNCTIONAL ASSESSMENT | BEVACIZUMAB | SUPPRESSION | TUMOR-GROWTH | AMG 386 | CHEMOTHERAPY | Care and treatment | Analysis | Carboplatin | Clinical trials | Product development | Ovarian cancer | Cancer
Journal Article
Journal Article
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, ISSN 1178-203X, 2011, Volume 7, Issue default, pp. 387 - 392
Patient-centered home care is a new model of assistance, which may be integrated with more traditional hospital-centered care especially in selected groups of... 
TRIAL | home care | MANAGEMENT | COSTS | biologic agents | HEALTH CARE SCIENCES & SERVICES | cancer | chemotherapy | Patients | Review
Journal Article
Rare Tumors, ISSN 2036-3605, 03/2017, Volume 9, Issue 1, pp. 7 - 8
Angiosarcoma of the scalp is a rare aggressive tumor that affects elderly patients. Chemoradiation is the treatment of choice for multicentric and extensive... 
Scalp irradiation | IGRT | Tomotherapy | IMRT | Angiosarcoma | Tomotherapy, IGRT, IMRT, Scalp irradiation, Angiosarcoma
Journal Article
Concurrency and Computation: Practice and Experience, ISSN 1532-0626, 11/2019
Journal Article
Rivista di storia economica, ISSN 0393-3415, 04/2015, Volume 31, Issue 1, pp. 25 - 56
// ABSTRACT IN ENGLISH: The Neo-sumerian state went on for 108 years (2159-2052 BC) and comprised both a core and a territory called Ma-da. The core included... 
Mesopotamia
Journal Article
Future Oncology, ISSN 1479-6694, 2014, Volume 10, Issue 5, pp. 725 - 733
Aims: Clinical activity of chemotherapy plus trastuzumab in HER2 overexpressing advanced breast cancer has been documented. We report the activity and safety... 
trastuzumab | gemcitabine | advanced breast cancer | docetaxel | HER2 overexpression | MULTICENTER | RECEPTOR | CHEMOTHERAPY | PACLITAXEL | TRIAL | ONCOGENE | AMPLIFICATION | ONCOLOGY | HER2 | EXPRESSION | PLUS
Journal Article
by Paz-Ares, Luis and Dvorkin, Mikhail and Chen, Chengshui and Chen, Yen-Hsun and Chen, Yuan and Chen, Yuanbin and Chen, Zhendong and Reinmuth, Niels and Hotta, Katsuyuki and Trukhin, Dmytro and Statsenko, Galina and Hochmair, Maximilian J and Özgüroğlu, Mustafa and Ji, Jun Ho and Voitko, Nataliia and Voitko, Oleksandr and Poltoratskiy, Artem and Ponce, Santiago and Verderame, Francesco and Havel, Libor and Bondarenko, Igor and Kazarnowicz, Andrzej and Losonczy, György and Conev, Nikolay V and Armstrong, Jon and Byrne, Natalie and Shire, Norah and Jiang, Haiyi and Goldman, Jonathan W and Batagelj, Emilio and Casarini, Ignacio and Pastor, Anea Viviana and Sena, Susana Noemi and Zarba, Juan Jose and Burghuber, Otto and Hartl, Sylvia and Lamprecht, Bernd and Studnicka, Michael and Alberto Schlittler, Luis and Augusto Martinelli de Oliveira, Fabricio and Calabrich, Aknar and Colagiovanni Girotto, Gustavo and Dos Reis, Peo and Fausto Nino Gorini, Carlos and Rafael Martins De Marchi, Peo and Serodio da Rocha Baldotto, Clarissa and Sette, Claudia and Zukin, Mauro and Dudov, Assen and Ilieva, Rumyana and Koynov, Krassimir and Krasteva, Rositsa and Tonev, Ivan and Valev, Spartak and Venkova, Violetka and Bi, Minghong and Fang, Jian and Feng, Jifeng and Han, Zhigang and Hu, Jie and Hu, Yi and Li, Wei and Li, Chien-Te and Liang, Zongan and Lin, Zhong and Ma, Shenglin and Ma, Rui and Nan, Kejun and Shu, Yongqian and Wang, Chin-Chou and Wang, Kai and Wang, Mengzhao and Wu, Gang and Wu, Shang-Yin and Yang, Nong and Yang, Zhixiong and Zhang, Wei and Zhang, Helong and Zhao, Yanqiu and Zhao, Jun and Zhou, Jianying and Zhou, Caicun and Zhou, Xiangdong and Kolek, Vitezslav and Koubkova, Leona and Roubec, Jaromir and Skrickova, Jana and Zemanova, Milada and Chouaid, Christos and Hilgers, Werner and Lena, Hervé and Moro-Sibilot, Denis and Robinet, Gilles and Souquet, Pierre-Jean and Alt, Jürgen and Bischoff, Helge and Grohe, Christian and Laack, Eckart and Lang, Susanne and Panse, Jens and ... and CASPIAN Investigators and CASPIAN investigators
The Lancet, ISSN 0140-6736, 11/2019, Volume 394, Issue 10212, pp. 1929 - 1939
Most patients with small-cell lung cancer (SCLC) have extensive-stage disease at presentation, and prognosis remains poor. Recently, immunotherapy has... 
PROPHYLACTIC CRANIAL IRRADIATION | SCLC | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | CISPLATIN | Antineoplastic Agents, Immunological - administration & dosage | Lung Neoplasms - drug therapy | Etoposide - adverse effects | Drug Administration Schedule | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols | Carboplatin - administration & dosage | Etoposide - administration & dosage | Male | Small Cell Lung Carcinoma - drug therapy | Cisplatin - administration & dosage | Carboplatin - adverse effects | Antineoplastic Agents, Immunological - adverse effects | Antineoplastic Agents, Phytogenic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal - administration & dosage | Progression-Free Survival | Cisplatin - adverse effects | Female | Small Cell Lung Carcinoma - mortality | Aged | Etoposide | Care and treatment | Product development | Lung cancer | Analysis | Drugs | Medical services | Radiation | Clinical trials | Metastasis | Cancer therapies | Randomization | Motivation | Platinum | Immunotherapy | Safety | Neutropenia | Small cell lung carcinoma | Maintenance | Radiation therapy | Survival | Patients | Cisplatin | Response rates | Carboplatin | Irradiation | Ligands | Clinical medicine | Solid tumors | Tumors | Apoptosis
Journal Article